

100 Years of Expertise in Vaccines
It is with great honor that IDT Biologika celebrates its 100th anniversary in 2021. Companies that reach this milestone typically share certain characteristics, like commitment and stability, but also inevitably requirements like adaptability and innovation. To thrive over 100 years, through much change, takes all these character traits and more, applied under consistent stewardship over the decades.
Our anniversary film.

Our anniversary film highlights the history of IDT Biologika from its beginnings as a start-up in 1921 to its big plans today.
Unsere Jubiläumsbroschüre
Lesen Sie mehr zu unserem Unternehmen – zu unserer Geschichte, unseren Plänen für die Zukunft und den Menschen im Unternehmen.
Our anniversary brochure
Read more about our company – about our history, our plans for the future and the people in the company.
Looking to the Future
At the beginning, there is no looking back, only forward. And that is a trait in itself. Despite 100 years in vaccines, IDT Biologika is always looking to the future, interpreting what the world needs from the next generation of vaccines and therapeutics.
Never have we seen a clearer embodiment of this than in our centenary year – when you think of the global COVID-19 pandemic on one hand and the rapid growth of cell and gene therapies and other exciting modalities on the other.
IDT continues to invest in state-of-the-art technologies, to nurture generations of expertise in our workforce, and to focus on innovation to ensure we remain at the forefront of development and manufacturing in products based on live viruses. Our goal is to continue to adapt and dedicate ourselves to whatever is needed in the coming years. And, who knows, that focus on the present may lead us to our next 100-year anniversary!